Helix Acquisition and BridgeBio Oncology receive SEC approval for merger

Go back to Helix Acquisition and BridgeBio Oncology receive SEC approval for merger
(NASDAQ: BBIO) Delayed: 69.36 +0.73 (1.06%)
Previous Close $68.63    52 Week High
Open $69.25    52 Week Low
Day High $70.77    P/E N/A 
Day Low $68.94    EPS
Volume 4,190,473       

(NASDAQ: HLXB) Delayed: 9.90 --0 (-0%)
Previous Close $9.90    52 Week High
Open $9.90    52 Week Low
Day High $9.90    P/E N/A 
Day Low $9.90    EPS
Volume 51,325